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The amyloid-related serum protein SAA appears to be a precursor of protein 
AA  (1,  2),  the  major  constituent  of  amyloid  fibrils  deposited  in  secondary 
amyloidosis (3).  We recently localized SAA-like material to fibrillar structures 
in fetal connective tissues by immunofluorescence microscopy (4). SAA was also 
detected  in  cultured  embryonal  fibroblasts:  the  fluorescence  was  cytoplasmic 
and formed a  fine  fibrillar  staining  pattern  (4).  It was  clearly  different  from 
collagen and reticulin fibers,  but showed certain similarities  with components 
of elastic fibers (4). The aim of the present report was to study the intracellular 
relation of the SAA-like material in fibroblasts. We have shown that the SAA- 
like  material  is  present  in  cytoskeletal  10-nm  intermediate  filaments  of the 
cultured fibroblasts, but not associated with microfilaments or microtubules. 
Materials  and Methods 
Cells  in  Tissue  Culture.  Human embryonal fibroblasts  (HEF) were prepared  by  trypsinization 
of  small pieces  of  body wall:  the  dissociated  cells  were plated  and maintained in secondary culture 
as described previously (4).  Cells  grown on small coverslips  were fixed  alter  2 days in culture in 
3.5% paraformaldehyde for  15  rain  and  subsequently  treated  with  acetone at -20°C for  20  rain.  The 
fixed  cells  were  washed in  phosphate-buffered saline,  pH 7.1  (PBS) for  at  least  30  rain.  Selected  cell 
cultures  were grown in  the  presence of  0.1 ~g/ml demecolcine (Colcemid, Ciba, Milan, Italy)  for  12 
h or with 10 ~g/ml vinblastine  sulphate (Eli  Lilly  and Co.,  Indianapolis,  Ind.)  for  3 h (5). 
Amyloid-Related Serum Protein SAA.  SAA was prepared from patient sera with high SAA 
activity  (1)  by gel filtration  in 10% formic acid (6). 
Antisera.  Antibodies against SAA were produced by immunization of  rabbits with purified 
SAA  in Freund's complete adjuvant (4).  The specificity  of these antibodies was assessed by 
immunodiffusion and indirect immunofluorescence (IFL) as reported previously (4, 6). 
Anti-actin antibodies were from sera of patients with active chronic hepatitis producing smooth 
muscle antibodies (SMA) with anti-actin specificity (7). The antibodies were used as markers for 
cytoplasmic actin filaments (7,  8). 
Immunofluoreseence  and Immunoperoxidase  Methods.  Binding of rabbit anti-human SAA to 
fixed normal demecolcine or vinblastine-treated fibroblasts was demonstrated by indirect immu- 
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nofluorescence by using fluorescein-isothiocyanate-conjugated sheep anti-rabbit  IgG (F/P molar 
ratio 2.0, 0.4 mg protein/ml) as previously described (4). The immunofluorescence was studied by 
using Zeise Standard  Microscope (Carl Zeise, Inc., Oberkochen, West Germany) equipped with 
epi-illuminator  IV FL and phase contrast optics. 
The immunoperoxidase localization method was essentially that described by Sternberger  and 
Cuculis (9). The cells were fixed in 3.5% paraformaldehyde for 15 rain and subsequently treated 
with 0.05% nonionic detergent  Nonidet P-40 (BDH) (Shell Chemical Co., New York) for 15 rain, 1 
incubated first with anti-SAA diluted in 1% goat serum, washed twice in PBS for 30 rain followed 
by sheep  anti-rabbit  IgG. Then  soluble complex of horseradish  peroxidase  and  rabbit  anti- 
horseradish peroxidase (PAP-complex, Dakopatts A.S., Copenhagen, Denmark) was added. After 
washing  in PBS for 90 min the enzymatic reaction  was developed with  3,3'-diaminobenzidin- 
tetrahydrochloride  (DAB) (Fluka  A.G.,  Buchs, Switzerland).  This  substrate  for the  enzyme 
reaction was made up as a 0.05% solution in 0.06 M Tris buffer pH 7.6, containing 0.003% HsOs. 
ARer 30 min  incubation,  the cells were washed  in  distilled  water.  For light microscopy the 
peroxidase-stained cells were mounted by using conventional methods. For electron microscopy 
the peroxidase.stained  cells were postfixed in 1% aqueous osmium tetroxide,  dehydrated,  and 
embedded in Epon 812. Ultrathin sections were studied in a Jeol 100 B electron microscope (Jeol 
Ltd., Tokyo, Japan). 
The specificity controls were essentially  as described previously (4). Rabbit anti-human SAA 
antiserum  was substituted  with normal rabbit serum and anti-SAA activity was neutralized both 
with  purified  human SAA and with  patient  sera  containing  SAA. In the  immunoenzymatic 
method an additional control included leaving out the PAP-complex  to detect endogenous peroxi- 
dase activity. This control was essentially negative. 
Electron Microscopy.  For electron microscopy, the cells were fixed in 3.5% glutaraldehyde, 
postfixed in 1% osmium tetroxide, dehydrated, and embedded in Epon 812. The ultrathin sections 
were stained with lead citrate  and uranyl acetate. 
Results 
Immunofluorescent Staining with Anti-SAA and Anti-Actin.  After staining 
with  anti-SAA a  fine fibrillar  fluorescence was seen  in  the  cytoplasm of em- 
bryonal fibroblasts  (Fig.  1 A). This staining pattern was clearly different from 
the filamentous staining produced by anti-actin antibodies.  Thus the SAA-like 
material detected by anti-SAA did not correspond to the cytoplasmic microfila- 
ments. 
Effects  of Drugs  Altering  Intracellular  Microtubules.  Further  studies  to 
localize  SAA-like material  intracellularly  were performed with  drugs,  which 
alter  intracellular  microtubules.  The  localization  of anti-SAA was  markedly 
altered in cells treated with demecolcine or vinblastine sulphate, as compared to 
untreated cells.  In treated  cells the immunofluorescence staining was usually 
seen  in  pronounced  perinuclear  bundles  of varying  diameter  (Fig.  1 B).  It 
sometimes formed a  perinuclear ring,  in  other cells  a  branching cytoplasmic 
network was seen. The fluorescent fibers and bundles were often localized in one 
segment  of the  cytoplasm.  The  most  intensely  stained  bundles  were  closely 
associated with the nucleus. The localization of SAA in vinblastine-treated cells 
did not differ from that of demecolcine-treated cells.  Vinblastine-induced para- 
crystals  were  seen  in  phase  contrast  microscopy  (Fig.  1 C).  They  were  not 
stained by anti-SAA in immunofluorescence (Fig.  1 D). 
The fibrillar immunofluorescence obtained with anti-SAA both in treated and 
in untreated cells was completely inhibited when the anti-SAA antiserum was 
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FIG.  1.  Localization of SAA-like material in cultured human embryonal fibroblasts. A. 
Fine  fibrillar  IFL  in  the  cytoplasm  with  anti-SAA.  B.  Perinuclear  immunofluorescent 
bundles with anti-SAA in cells cultured in the presence of demecolcine.  C.  Cytoplasmic 
paracrystals  (arrows)  in  cells  cultured  in  the  presence  of vinblastine sulphate.  Phase 
contrast micrograph. D. IFL staining with anti-SAA of the same cells as in Fig. 1 C  x  2,000. 
preincubated with purified SAA protein in a concentration of 10/~g/ml or with 
SAA-containing  patient sera in dilutions  up to 400.  The  fluorescence was not 
affected when absorbed with SAA-negative sera. 
Ultrastructural Studies.  In thin sections of demecolcine-treated fibroblasts, 
bundles of filaments were seen at the perinuclear regions in electron microscopy 
(Fig.  2). They consisted of intermediate  filaments with an average diameter of 
10  nm.  By using  immunoperoxidase  labeling  technique,  the  relationship  be- 
tween these 10-nm intermediate fibrils and the SAA-like material detected by 
anti-SAA  was further  investigated.  Light microscopic analysis of peroxidase- 
stained fibroblasts demonstrated patterns analogous to those seen in immuno- 
fluorescence microscopy with anti-SAA antiserum.  (Fig. 3, insert).  In addition, 
when the demecolcine-treated cells were studied by immunoelectron microscopy 
with  anti-SAA  (Fig.  3),  the  peroxidase  reaction  product  was  localized to the 
perinuclear  bundles  of 10-nm  filaments  similar to  that  identified  by electron 
microscopy in  Fig.  2.  The  specificity of the  staining  reaction  was  proved by 
blocking  experiments  where  isolated  SAA  and  SAA-positive,  but  not  SAA- 
negative  sera,  totally inhibited  the  reaction.  Thus  the  SAA-like  material  as LINDER  ET  AL.  BRIEF  DEFINITIVE  REPORT  1161 
FIa.  2.  Electron micrograph from a  human embryonal fibroblast treated with demecol- 
cine. Bundles of  intermediate filaments (arrows), about 10 nm in diameter, are seen perinu- 
clearly. N, nucleus.  ×  35,000. 
detected by specific anti-SAA antisera  corresponded to the intracellular  lO-nm 
filaments of the fibroblasts. 
Discussion 
In  the  present  study  we  have  localized  SAA-like  material  to  cytoplasmic 
intermediate  (10  nm)  filaments  in  fibroblasts  by  IFL  and  immunoelectron 
microscopy. The intermediate filaments constitute part of  the cellular cytoskele- 
ton (10,  11). In this study we differentiated these filaments from other fibrillar 
cytoplasmic structures,  microfilaments  and  microtubules,  on the basis of the 
unique  property of the  intermediate  filaments  to form  bundles  when  treated 
with demecolcine and vinblastine  (8,  12). 
The fibrillar fluorescence in intermediate filaments was clearly distinct from 
the  pattern  produced  by anti-actin  antibodies  which  react  with  cytoplasmic 
microfilaments  (5,  8).  On the other hand,  SAA-like material  seem to be unre- 
lated to microtubules  as well;  vinblastine  treatment  causes fragmentation  of 
microtubules and formation of tubulin-containing  paracrystals.  Such microtu- 
bules-derived material did not stain in IFL with anti-SAA. 
Intermediate filaments seem to be ubiquitous occurring in e.g. smooth muscle 
cells  (11),  vascular  endothelium  (12),  and  neural  cells  (13),  but the  problem 
whether SAA is present in 10-nm filaments of different cellular origin remains 
to be solved.  However,  the  fluorescence seen  in  liver  sinusoids  (4)  and  fetal 
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FIG. 3.  Immunoperoxidase  localization with  anti-SAA  of SAA-like  material  in  cells 
treated with demecolcine. In  light  microscopy  perinuclear  bundles are  seen  similar to  those 
seen in IFL (insert).  In electron microscopy the peroxidase reaction product is  localized  to 
perinuclear  intermediate filament bundles (arrow). N, nucleus.  × 42,000. 
SAA-like material might be present also in 10-nm filaments of other cell types 
than  fibroblasts.  Previous  immunofluorescence  studies  suggested  that  SAA 
might  be  related  to  the  microfibrillar  component  of elastic  fibers  (14).  This 
component has a size of about 10-11 nm (100-110/k) (15) and this corresponds to 
the size of the intracellular filaments which react with anti-SAA. Studies on the 
composition of 10-nm filaments have shown one major component, desmin, with 
a  tool wt of about 55,000  (12).  Further studies are presently being performed to 
see whether these  morphological  and  antigenic  similarities  reflect a  common 
biochemical composition. 
Summary 
Further studies are presented on the intracellular localization of the amyloid- 
related  serum  protein  SAA  previously  shown  to  be  produced  by  embryonal 
fibroblasts.  In  cultured  embryonal  fibroblasts,  the  fine  fibrillar  cytoplasmic 
immunofluorescence obtained by anti-SAA was distinguished from that of mi- 
crofilaments and microtubules.  By using electron microscopy and cells treated 
with drugs known to specifically alter intracellular fibrils, SAA was localized to 
10-nm intermediate size filaments. These filaments form characteristic perinu- 
clear bundles  upon treatment  with  drugs  such  as demecolcine or vinblastine LINDER  ET AL.  BRIEF  DEFINITIVE  REPORT  1163 
which disrupt micotubules. The results indicate that SAA is a constituent of the 
intracellular cytoskeleton. 
Received for publication 27 June 1977. 
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